Psychedelic substances—especially psilocybin, the active compound in so-called “magic mushrooms”—have received growing attention in the United States because of research into their potential medical uses. However, the science is still evolving, and these substances are not a general wellness supplement.

What researchers are studying

Clinical trials have investigated psilocybin-assisted therapy for conditions such as:

• Major depressive disorder
• Treatment-resistant depression
• Anxiety associated with serious illness
• Post-traumatic stress disorder (PTSD)
• Substance use disorders, including alcohol and nicotine dependence

Several studies have reported promising results, particularly when psilocybin is administered in carefully controlled settings with psychological support. However, researchers emphasize that more large-scale studies are needed before widespread medical use.

Potential benefits

Some participants in clinical trials have experienced:

• Reduced symptoms of depression and anxiety
• Increased emotional openness and well-being
• Long-lasting changes in mood and perspective
• Reduced cravings in certain addiction treatments

These effects appear to depend heavily on factors such as dosage, the person’s mental health history, and the therapeutic environment.

Risks and side effects

Psilocybin is not risk-free. Possible adverse effects include:

• Intense fear or panic during the experience
• Confusion or impaired judgment
• Nausea and increased heart rate
• Worsening of psychotic disorders in susceptible individuals
• Rare but potentially dangerous behaviors if taken without supervision

Because of these risks, people with a personal or family history of schizophrenia or certain bipolar disorders are generally advised to avoid psychedelic substances unless under specialized medical care.

Legal status in the U.S.

Psilocybin remains illegal under U.S. federal law, although some states and cities have decriminalized or created regulated therapeutic programs. Oregon and Colorado have established frameworks for supervised psilocybin services, and several other states are considering similar measures.

Bottom line

Current evidence suggests that psilocybin may have therapeutic potential for specific mental health conditions when used under professional supervision, but there is not enough evidence to recommend “magic mushrooms” for general health improvement or self-treatment. Anyone considering psychedelic therapy should consult qualified healthcare professionals and be aware of the laws in their jurisdiction.